Speaker illustration

Doctor Byambasuren Ganbaatar

Institute of Health Biosciences- The University of Tokushima Graduate School, Tokushima (Japan)

Empagliflozin, a SGLT2 inhibitor, attenuates endothelial dysfunction and atherogenesis by inhibiting inflammatory responses in the vasculature and adipose tissue in diabetic apolipoprotein E-deficient

Event: ESC Congress 2019

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Session: Vascular remodelling from capillaries to aorta

Thumbnail

Inhibition of S1P2 receptor ameliorates endothelial dysfunction and prevents atherogenesis in apolipoprotein-E-deficient Mice

Event: ESC Congress 2018

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Session: Vascular disease and endothelium

Thumbnail

Atheroprotective effects of ticagrelor, a P2Y12 antagonist, in apolipoprotein-E-deficient mice

Event: ESC Congress 2018

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Session: Inflammation and microcirculation

Thumbnail